A growing body of evidence places skeletal muscle—via its impact on insulin resistance and systemic inflammation—and the muscle-liver axis at the center of the NAFLD pathogenic cascade. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.